MAIA platform for routine clinical testing: an artificial intelligence embryo selection tool developed to assist embryologists

MAIA平台用于常规临床检测:一种为辅助胚胎学家开发的基于人工智能的胚胎选择工具

阅读:1

Abstract

The need to reduce the number of embryos transferred in assisted reproductive care to prevent multiple gestations has led to a stronger emphasis on selecting embryos with the highest morphological quality. Although this evaluation has traditionally been performed by trained embryologists, the increasing use of time-lapse incubators has introduced a greater volume of data and subjectivity in decision-making. Artificial intelligence (AI)-based tools can support embryologists by offering objective, standardized embryo assessments.In Brazil, like other countries, where imported embryo selection technologies may not account for local demographic and ethnic profiles, an AI model - Morphological Artificial Intelligence Assistance (MAIA) - was developed through a collaboration between a university and a private fertility clinic in São Paulo. The model was trained using 1,015 embryo images and prospectively tested in a clinical setting on 200 single embryo transfers. In clinical testing, MAIA achieved an overall accuracy of 66.5%. In elective embryo transfers, where there were more than one embryo eligible for transfer, MAIA achieved 70.1% accuracy for predicting clinical pregnancy. Designed with a user-friendly interface tailored by embryologists, MAIA provides real-time embryo evaluations to support decision-making in routine care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。